期刊文献+

遗传性非典型溶血尿毒综合征的病因及诊治 被引量:1

下载PDF
导出
摘要 溶血尿毒综合征(hemolytic uremic syndrome,HUS)是一种以微血管性溶血性贫血、急性肾衰竭和血小板减少三联症为临床特征的疾病。1955年首先由Gesser等描述,是小儿急性肾衰竭的常见原发病之一^[1]。HUS分典型和非典型溶血尿毒综合征(atypical hemolytic uremic syndrome,aHUS)两大类,前者以埃希大肠杆菌O157:H7感染所致,又称D+HUS(diarrhea-associated HUS),复发率低。后者无腹泻诱因,又称D-HUS(HUS not associated diarrhea),占HUS的5%~10%,预后差,复发率高。aHUS呈散发性和家族性,与遗传有关,可为常染色体显性和隐性遗传。近年来对与遗传有关的aHUS的病因、诊断及治疗的研究有了较大进展,本文就此进行讨论,以期对临床工作有所借鉴。
作者 李弢
出处 《临床肾脏病杂志》 2008年第8期346-349,共4页 Journal Of Clinical Nephrology
  • 相关文献

参考文献18

  • 1Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol, 2005,16: 1035-1050.
  • 2Vaziri-Sani F, Hellwage J, Zipfel PF, et al. Factor H binds to washed human platelets. J Thromb Haemost, 2005,3 : 154-162.
  • 3Richards A, Buddles MR, Donne RL, et al. Factor H mutations in heamolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J Hum Genet, 2001,68: 485-490.
  • 4Dragon Durey MA, Fremeaur-Bacchi V, Loirat C, et al. Heterozygous and homozygous factor H difficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J Am Soc Nephrol, 2004,15 : 787-795.
  • 5Caprioli J,Castelletti F, Bucchioni S, et al. Complement factor H mutations and gene polymorphisms in hemolytic uremic syndrome:the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Human Mol Genet, 2003.12 : 3385-3395.
  • 6Pangburn MK. Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl terminal:ira plications for hemolytic uremic syndrome. J Immunol, 2002,109: 4702-4706.
  • 7Barilla LaBarca MI.. I.iazewaki MK, Lambris JD, et al. Role of membrane cofactor protein(CD46) in regulation of C4b and C3b deposited on cells. J Immunol, 2002,168 : 6298-6304.
  • 8Richards A, Kemp EJ, Liszeuski MK, et al. Mutations in human complement regulator, membrane cofactor protein (CD46 ), pre dispoee to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci USA,2003. 100:12966-12971.
  • 9Blorn AM, Kask L, Dahlback B. CCP1-4 of the C4b binding prorein alpha chain are required for factor 1 mediated cleavage of complement factor C3b. J Mol Immunol. 2003,39:547-556.
  • 10Kavanagh D, Kemp EJ. Mayland E, et al. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soe Nephrol, 2005,16 : 2150-2155.

同被引文献8

  • 1梅国花,张晨美,杜立中,刘涛,叶盛.小儿溶血尿毒综合征28例临床分析[J].浙江医学,2007,29(6):550-552. 被引量:3
  • 2刘平.溶血性尿毒症综合征.见:王海燕,主编.肾脏病学.第2版.北京:人民卫生出版社,1998.1021-1029.
  • 3Jokiranta TS, Zipfel PF, Fremeaux - Bacchi V, et al. Where next with atypical hemolytic uremic syndrome. Mol Immunol, 2007,44 : 3889-3900.
  • 4Chen YC, Chen HS, Shen C J, et al. Delayed postpartum hemorrhage- - a rare clinical presentation of thrombotic thrombocyto-penic purpura- hemolytic uremic syndrome., a case report. Kaohsiung J Med Sci,2005,21 :532-535.
  • 5Razzaq S. Hemolytic uremic syndrome: an emerging health risk. Am Faro Physician, 2006,74 : 991-996.
  • 6Nangaku M, Nishi H, Fujita T. Pathogenesis and prognosis of thrombotic microangiopathy. Clin Exp Nephrol,2007,11:107-114.
  • 7党建中,贾汝汉,刘红燕,王学玉.溶血性尿毒症性综合征14例临床分析[J].临床肾脏病杂志,2008,8(5):215-217. 被引量:1
  • 8张毓文,孟群,周春菊.35年来小儿溶血尿毒综合征流行概况、死亡病例分析和治疗进展[J].临床儿科杂志,2003,21(9):545-548. 被引量:23

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部